Psychiatry and Neurology, Neurology · Aliso Viejo, CA
NPI
1508012139
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
26671 Aliso Creek Rd Ste 203
Aliso Viejo, CA, 92656
Phone (949) 397-9205
Groups this clinician bills Medicare through
Medicare paid, 2024
$174K
2,902 services
Medicare patients, 2024
232
Average age 74
Drug cost, 2024
$1.2M
2,562 prescriptions
Company payments, 2025
$204K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mindy K Bixby was code 99215 (office e&m - established), 636 times for 193 patients. In total Mindy K Bixby billed 2,902 services in 33 codes, and Medicare paid $174K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 636 | 193 | $130.42 | $83K |
| 95984 Electrical Nerve Conductivity | Office | 219 | 16 | $34.37 | $7,527 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 175 | 109 | $25.44 | $4,452 |
| 99214 Office E&M - Established | Office | 124 | 87 | $83.90 | $10K |
| 99213 Office E&M - Established | Office | 107 | 64 | $58.75 | $6,286 |
| 95874 Musculoskeletal | Office | 85 | 40 | $64.36 | $5,471 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 78 | 57 | $13.01 | $1,015 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 75 | 69 | $96.59 | $7,244 |
| 99497 Care Management/Coordination | Office | 75 | 62 | $63.69 | $4,776 |
| 95983 Electrical Nerve Conductivity | Office | 61 | 19 | $39.38 | $2,402 |
| 64642 Musculoskeletal | Office | 61 | 25 | $92.41 | $5,637 |
| 64616 Musculoskeletal | Office | 53 | 23 | $147.36 | $7,810 |
| 64643 Musculoskeletal | Office | 44 | 17 | $73.52 | $3,235 |
| 99205 Office E&M - New | Office | 40 | 40 | $155.16 | $6,206 |
| 64615 Musculoskeletal | Office | 40 | 16 | $106.04 | $4,242 |
By year: 2022 $101K for 1,015 services; 2023 $120K for 1,291 services; 2024 $174K for 2,902 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mindy K Bixby prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 480 prescriptions and refills. In total Mindy K Bixby wrote 2,562 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 480 | 1,269 | 156 | $27K |
| Rytary Carbidopa/Levodopa | 274 | 476 | 47 | $311K |
| Clonazepam Generic | 83 | 105 | 23 | $827 |
| Propranolol Hcl Generic | 80 | 196 | 26 | $3,102 |
| Gabapentin Generic | 72 | 157 | 25 | $1,684 |
| Rivastigmine Generic | 71 | 133 | 20 | $14K |
| Amantadine Amantadine Hcl | 61 | 147 | 24 | $4,543 |
| Rasagiline Mesylate Generic | 59 | 165 | 16 | $11K |
| Escitalopram Oxalate Generic | 57 | 157 | 18 | $613 |
| Memantine Hcl Generic | 55 | 127 | 18 | $1,261 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 55 | 139 | 16 | $5,975 |
| Nuplazid Pimavanserin Tartrate | 47 | 47 | Under 11 | $222K |
| Duloxetine Hcl Generic | 45 | 104 | 12 | $1,376 |
| Gocovri Amantadine Hcl | 44 | 52 | Under 11 | $163K |
| Trazodone Hcl Generic | 43 | 85 | 15 | $344 |
Brand drugs: 600 claims; generic drugs: 1,962 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mindy K Bixby $204K ($49K in general payments such as food, travel and fees and $155K for research) from 13 companies. The largest payer was Amneal Pharmaceuticals LLC with $195K.
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC AMRX | 44 | $195K |
| Zambon USA Ltd. | 1 | $7,500 |
| Abbvie Inc. ABBV | 51 | $877 |
| Medtronic, Inc. MDT | 9 | $181 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 6 | $141 |
| Abbott Laboratories ABT | 4 | $134 |
| MDD US Operations, LLC | 3 | $55.82 |
| Lundbeck LLC | 2 | $48.73 |
| ACADIA Pharmaceuticals Inc ACAD | 2 | $48.37 |
| Axsome Therapeutics, Inc. AXSM | 1 | $41.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.